StreetAlpha.app
Home › Stocks › FMS

Fresenius Medical Care AG (FMS)

Healthcare
$21.70
▼ −0.80%
LAST CLOSE · NOV 17

Fresenius Medical Care makes dialysis products and runs dialysis clinics for people with kidney disease. It last closed at $21.70 on Nov 17, down 0.80% on the day.

AI Auto Pilots
Is FMS in one of our four AI portfolios? Sign in free to see

Key Stats

Last 12 months
Results
Revenue
EUR 19.6B
+1.5% vs a year ago
Net income
EUR 978.4M
+81.9% vs a year ago
Operating margin
9.3%
EUR 1.8B operating income
Balance sheet
Cash & equivalents
EUR 1.6B
At Dec 31
Debt
EUR 10.8B
At Dec 31
Shareholder equity
EUR 14.3B
ExchangeNYSE
Financials history
FY2021: EUR 17.6BEUR 17.6BFY2021FY2022: EUR 19.4BEUR 19.4BFY2022FY2023: EUR 19.5BEUR 19.5BFY2023FY2024: EUR 19.3BEUR 19.3BFY2024FY2025: EUR 19.6BEUR 19.6BFY2025

From FMS's SEC filings, latest 20-F for the period ending Dec 31, 2025 (filed Feb 24). Last 12 months adds up the four latest quarters. Figures are in EUR. Per share figures are left out because the US listing can represent a different number of shares.

Next report
—
No date on the calendar yet
Consensus EPS forecast
—
 
Year-ago EPS
—
Not on file
Options-implied move
—
 
Analyst consensus
1 Hold
1 firm · not enough for a consensus
Loading…

Analyst Ratings & Price Targets

Analyst Ratings →
Ratings · 90 days
1 Hold
1firm
0 Buy1 Hold0 Sell
Only 1 firm rated FMS in the past 90 days, not enough for a consensus
Average 12-month target
$24.00
▲ 10.6% upside

Based on 1 analyst who set a price target on FMS in the past 90 days. The average target is $24.00, with a high of $24.00 and a low of $24.00, compared with the last close of $21.70.

Low $24.00Avg $24.00High $24.00
Blue marker: last close $21.70
Highest target$24.00
Average target$24.00
Lowest target$24.00
Latest rating changes
Truist SecuritiesMaintained
Oct 12Hold$24
BernsteinMaintained
Aug 6Hold$25.80
DateFirmActionRatingPrice target
Oct 12Truist SecuritiesMaintainedHold$24
Aug 6BernsteinMaintainedHold$25.80
Loading…

Technical Analysis

FMS · as of the Nov 17 close · updated after every close
Downtrend

The stock is 4% below its 20 day and 3% below its 50 day average. It is 6% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 44). The nearest support is the Pivot S1 at $21.60, and the nearest resistance the Pivot at $21.77.

Short trendBearish
Long trendBearish
MomentumWeak
StretchNormal
VolatilityHigh, 2.7%/day
Key levels
$26.4252 week high+21.8%
$23.04100 day average+6.2%
$22.90200 day average+5.5%
$22.4820 day average+3.6%
$22.38Swing high (Oct 16)+3.1%
$22.2650 day average+2.6%
$21.86Pivot R1+0.7%
$21.77Pivot+0.3%
$21.70Last close
$21.60Pivot S1−0.5%
$21.56Swing low (Nov 12)−0.6%
$20.0252 week low−7.7%
Indicators
RSI (14)43.97Middle of its rangeNeutral
MACD-0.07Below its signal lineBearish
Stochastic17.3Near the bottom of its rangeOversold
ADX (14)14.1No clear trend
Williams %R-90.0Oversold below −80, overbought above −20Oversold
CCI (20)-101.2Oversold below −100, overbought above 100Oversold
Rate of change−0.1%Change over 10 sessionsBearish
ATR (14)$0.58Typical daily range, 2.7% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for FMS

What happened before

See how FMS did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.

November seasonalityHow FMS usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

Seasonality

How FMS has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2006.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D

No whale options trades in FMS in the last 90 days.

Loading…

See today’s whale options flow across the market →

FMS Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Bearish
Strongly bearishNeutralStrongly bullish
  • ●114 buying vs 100 selling
  • ▼Shares held by funds -2.9%
  • ▼Funds holding -8
  • ▼Superinvestors: 0 added, 3 cut
  • ●Put/call not meaningful
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holding
Q3 2026This quarterLast quarterChange
Funds holding229237−3.4%
In funds' top 1000–
Held by funds–––
New / increased30 / 8445 / 104−23.5%
Reduced / sold out64 / 3643 / 29+38.9%
Put/call ratio–––
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See FMS institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

AI Auto Pilots

Paper trading

StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether FMS is in one of them and how their past FMS trades turned out.

FMS in the AI portfolios
Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered FMS in an article yet. Here's the latest on the wider market.

FMS Congress Trades

All congress trades →
Trades, 12 months
0
Buys
0
Sells
0
People
0
Last filed Aug 13
Who traded FMS · since 2018
Latest 5 filings of 17
$1K – $15KTraded Jul 10, 2023Filed Aug 13, 2023
$15K – $50KTraded Sep 2, 2022Filed Oct 13, 2022
$15K – $50KTraded Sep 2, 2022Filed Oct 13, 2022
$1K – $15KTraded Dec 14, 2021Filed Jan 27, 2022
$15K – $50KTraded Mar 19, 2021Filed Apr 19, 2021
PersonTypeAmountTradedFiledDelay
Dan GoldmanD · NYSell$1K – $15KJul 10, 2023Aug 13, 202334 d
Michael McCaulR · TXSell$15K – $50KSep 2, 2022Oct 13, 202241 d
Michael McCaulR · TXSell$15K – $50KSep 2, 2022Oct 13, 202241 d
Michael McCaulR · TXSell$1K – $15KDec 14, 2021Jan 27, 202244 d
Michael McCaulR · TXBuy$15K – $50KMar 19, 2021Apr 19, 202131 d

Members of Congress and senior officials report trades up to 45 days later, as dollar ranges. Filings show a trade happened, not why. Not investment advice.

About Fresenius Medical Care AG

Fresenius Medical Care provides products and services for people with kidney disease. It runs dialysis clinics and makes dialysis machines, disposable products, and pharmaceuticals used in kidney care. Its care can be delivered at its own treatment centers, in hospitals, at home, or while patients are traveling. Its customers include patients with kidney failure and hospitals that contract for dialysis services. The company is based in Bad Homburg, Germany.

Headquarters
Bad Homburg, Germany